Skip to main content
. 2022 Mar 24;46(2):198–221. doi: 10.4093/dmj.2021.0347

Fig. 2.

Fig. 2.

Graphical representation of publications examining diabetic peripheral neuropathy (DPN) endpoints in diet+chemically induced (blue) or transgenic (orange) rat models of type 2 diabetes mellitus before (pre) and after (post) the publication of the Neurodiab guidelines for phenotyping DPN in 2014. Dark shading and percentage values indicate the number of studies that assessed 3 DPN endpoints as recommended.